Blue Arbor Technologies Announces Strategic Partnership with Ottobock and $5 Million Investment to Advance RESTORE™ Neuromuscular Interface System
FDA breakthrough–designated RESTORE System designed to enable intuitive prosthetic control, [...]
Abram Scientific Secures $11.75M Series A Funding Led by Octapharma AG
Financing will accelerate the development of proprietary portable diagnostic platform, [...]
ProSomnus Secures $38 Million Strategic Investment from Catalio Capital Management to Scale Smart Sleep Medicine™
Strategic alliance focuses on scaling data-integrated sleep solutions to meet [...]
Simpson Interventions Announces Initial Series C Close and Rebrands as Elumn8 Medical
Series C financing supports continued clinical development of the Acolyte [...]
Johnson & Johnson Boosts U.S. Presence with $1 Billion+ Investment in Next‑Gen Cell Therapy Facility
Advanced manufacturing site will utilize cutting‑edge cell therapy technologies to [...]
GENFIT to receive US$20M milestone after Ipsen’s Iqirvo® exceeds the US$200M threshold in its first full year of net sales
GENFIT will publish its 4Q25 revenue and cash position on [...]
PranaX Corporation Announces $17M Oversubscribed Series A
The Series A round was led by family offices, trusts, [...]
Axol Bioscience raises $2.8M to advance US expansion and product development
Financing led by US life sciences investor, BroadOak Capital Partners [...]
AngelEye Health Secures Additional $9 Million to Accelerate Innovation in Neonatal and Pediatric Care
The round was led by existing investor Mountain Group Partners, [...]
Saluda Medical Raises $150M USD to Fuel Growth Following ASX IPO
This IPO and capital raise mark an important moment for [...]